A Study of Remimazolam Tosilate for Sedation in the ICU

NCT05152303 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Sedation in the ICU

Interventions

DRUG: Remimazolam Tosilate
DRUG: Remimazolam Tosilate

Sponsor

Fujian Shengdi Pharmaceutical Co., Ltd.